A39G (p.Ala39Gly) variant of NLGN3 (Neuroligin-3)
A39G (p.Ala39Gly) in NLGN3 (Neuroligin-3) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and published literature.
A39G (p.Ala39Gly) variant details
- p.Ala39Gly
- gnomAD X-71147865-C-G
- Missense
- Variant Prioritization Score for Impact Estimate 0.28
- REVEL 0.15
- CADD 16.60
- PolyPhen-2 0.01
- SIFT 0.38
- Population evidence available
- Literature evidence available